您的位置: 首页 > 2022年11月 第52卷 第6期 > 文字全文
2023年7月 第38卷 第7期11
目录

广东粤西北农村妇女高危型HPV感染情况分析

Analysis of high-risk HPV infection among rural women in northwestern Guangdong

来源期刊: 广州医药 | 22-26 发布时间:2022-11-30 收稿时间:2025/11/13 18:14:11 阅读量:123
作者:
关键词:
农村妇女宫颈癌筛查高危型人乳头瘤病毒
postmenopausal womencervical cancer screeninghigh risk HPV
DOI:
10.3969/j.issn.1000-8535.2022.06.005
收稿时间:
2022-01-12 
修订日期:
 
接收日期:
 
引用总数:
1  
目的 了解广东肇庆怀集县农村妇女两年来“两癌”检测的阳性情况及高危型人乳头瘤病毒(HPV)的感染特点。 方法 对2018年1月—2019年12月24 146名参与“两癌”免费检测的35~64 岁、农村妇女的宫颈癌筛查结果进行分析。以高危型HPV检测作为初筛方法,结果为HPV16、18型阳性的转诊阴道镜检查,其它高危型HPV阳性则进行薄层宫颈液基细胞学检查(TCT),TCT结果严重于或等于未明确意义的非典型鳞状上皮(ASC-US)者转诊阴道镜,阴道镜结果可疑或异常者进行组织病理学检查。 结果 高危型HPV总检出率为9.35%,单独HPV16、18和其它高危型HPV的阳性检出率分别为0.70%、0.32%、7.72%,混合感染检出率为0.61%,高危型 HPV 总检出率最高的年龄段是 60~64岁,检出率为11.22%。细胞学转诊率为65.63%,阴道镜转诊率为61.23%。宫颈癌前病变检出率为323.03/10 万,宫颈癌的检出率为45.56/10 万,早期诊断率为87.64%。宫颈癌前病变和宫颈癌的HPV16、18及混合感染占70.79%。 结论 该地区高危型HPV阳性率、宫颈癌前病变及宫颈癌检出率均较高,宫颈癌筛查异常者细胞学及阴道镜转诊率较低,提示该地区存在更高的宫颈癌发病风险。
Objective To understand the positive screening results and the infection characteristics of high-risk human papillomavirus (HPV) in Huaiji County,Guangdong Province,in the two years of the free standardization testing for rural women's “two cancers”. Methods The cervical cancer screening results of 35~64 year-old women with rural household registration who volunteered to participate in the “two cancers” free testing for rural women in the region were analyzed. High-risk HPV testing was used as the primary screening method for cervical cancer. The results of HPV16 and 18 positive patients were directly referred to colposcopy. If other high-risk HPV was positive,thin-layer cervical fluid-based cytology(TCT) was perform on those patients,whose TCT result severer than atypical squamous cells of undetermined significance (ASC-US) were referred to colposcopy,and those with suspicious or abnormal colposcopy results were referred to histopathological examination. Results The total positive detection rate of high-risk HPV was 9.35%. The positive rates of HPV16,18 and other high-risk HPV were 0.70%,0.32% and 7.72% respectively,mixed infection rate was 0.61%. The age group with the highest overall positive rate of high-risk HPV is 60-64 years old,and the rate is 11.22%. The referral rate for cytology was 65.63%,and the referral rate for colposcopy was 61.23%. The positive rate of cervical precancerous lesions was 323.03/100 000,the positive rate of cervical cancer was 45.5/100 000,and the early diagnosis rate was 87.64%.HPV16,18 and HPV mixed infections of cervical precancerous lesions and cervical cancer accounted for 70.79%.Conclusions The positive rate of high-risk HPV,cervical precancerous lesions and cervical cancer positive rate were high in this area. The being referred rate of cytology and colposcopy in cervical cancer screening was low,suggesting that there was a higher incidence of cervical cancer in this area risk.
1、 董航, 刘华章, 林国桢, 等. 广州市2004-2013年户籍人口宫颈癌与宫体癌死亡趋势分析与比较[J]. 疾病监测, 2016, 31(9): 755-760. 董航, 刘华章, 林国桢, 等. 广州市2004-2013年户籍人口宫颈癌与宫体癌死亡趋势分析与比较[J]. 疾病监测, 2016, 31(9): 755-760.
2、 武丽,吕霄,刘婷艳,等. 广东省农村妇女宫颈癌筛查质量及问题探究[J]. 中国妇幼保健, 2016, 31(5): 909-910. 武丽,吕霄,刘婷艳,等. 广东省农村妇女宫颈癌筛查质量及问题探究[J]. 中国妇幼保健, 2016, 31(5): 909-910.
3、 罗晓敏, 宋莉, 吴久玲, 等. 中国农村妇女宫颈癌检查项目2012和2013年上报数据结果分析[J]. 中华预防医学杂志, 2016, 50 (4): 346-350. 罗晓敏, 宋莉, 吴久玲, 等. 中国农村妇女宫颈癌检查项目2012和2013年上报数据结果分析[J]. 中华预防医学杂志, 2016, 50 (4): 346-350.
4、 THOMAS JO, HERRERO R, OMIGBODUN AA, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study[J]. Br J Cancer, 2004, 90(3): 638-645. THOMAS JO, HERRERO R, OMIGBODUN AA, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study[J]. Br J Cancer, 2004, 90(3): 638-645.
5、 SCHIFFMAN M,CASTLE PE. Human papillomavirus: epidemiology and public health[J]. Arch Pathol Lab Med, 2003, 127(8): 930-934. SCHIFFMAN M,CASTLE PE. Human papillomavirus: epidemiology and public health[J]. Arch Pathol Lab Med, 2003, 127(8): 930-934.
6、 EZEBIALUC U,EZEBIALUI U,EZEIFEKAG O,et al. Prevalence of cervical human pappillomavirus infection in Awka,Nigeria[J]. J Biosci Med, 2020, 8(3): 37-47. EZEBIALUC U,EZEBIALUI U,EZEIFEKAG O,et al. Prevalence of cervical human pappillomavirus infection in Awka,Nigeria[J]. J Biosci Med, 2020, 8(3): 37-47.
7、 赵娜,赵方辉,高晓红,等.城市和农村妇女高危型人乳头瘤病毒感染的危险因素分析[J]. 中华肿瘤防治杂志,2011, 18(16): 1225-1229. 赵娜,赵方辉,高晓红,等.城市和农村妇女高危型人乳头瘤病毒感染的危险因素分析[J]. 中华肿瘤防治杂志,2011, 18(16): 1225-1229.
8、 WANG R, GUO X, WISMAN G B A, et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China[J]. BMC lnfect Dis, 2015, (15):257-267. WANG R, GUO X, WISMAN G B A, et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China[J]. BMC lnfect Dis, 2015, (15):257-267.
9、 高丽丽,沈洁,张月,等. 北京地区35~64岁农村妇女高危型HPV感染情况分析[J]. 中国妇产科临床杂志,2015,6(16): 494-497. 高丽丽,沈洁,张月,等. 北京地区35~64岁农村妇女高危型HPV感染情况分析[J]. 中国妇产科临床杂志,2015,6(16): 494-497.
10、 黄千峰, 张秀, 邓娟琼,等. 农村12148名绝经后妇女宫颈癌筛查结果分析[J]. 解剖学研究, 2020(3):4. 黄千峰, 张秀, 邓娟琼,等. 农村12148名绝经后妇女宫颈癌筛查结果分析[J]. 解剖学研究, 2020(3):4.
11、 PLUMMER M, PETO J, FRANCESCHI S. International collaboration of epidemiological studies of cervical cancer. Time since first sexual intercourse and the risk of cervical cancer[J]. Int J Cancer, 2012, 130(11): 2638-2644. PLUMMER M, PETO J, FRANCESCHI S. International collaboration of epidemiological studies of cervical cancer. Time since first sexual intercourse and the risk of cervical cancer[J]. Int J Cancer, 2012, 130(11): 2638-2644.
12、 HENRI E, PAUL E, ROGER E, et al. HIV+ Status and cervical cancer: cytological cspects of cervical cmear in cameroon cetting[J]. Open J Obstet Gynecol, 2020(10): 76-84. HENRI E, PAUL E, ROGER E, et al. HIV+ Status and cervical cancer: cytological cspects of cervical cmear in cameroon cetting[J]. Open J Obstet Gynecol, 2020(10): 76-84.
13、 朱正,黄冠,赵海燕. 联合检测宫颈脱落细胞HTERC基因及HR-HPV病毒负荷量对宫颈癌筛查预测的意义[J]. 解剖学研究, 2013, 35(4): 269-272. 朱正,黄冠,赵海燕. 联合检测宫颈脱落细胞HTERC基因及HR-HPV病毒负荷量对宫颈癌筛查预测的意义[J]. 解剖学研究, 2013, 35(4): 269-272.
14、 安娜,段颜,杨鑫鑫,等. 宫颈上皮内瘤样病变患者阴道微环境平衡和HPV感染及危险因素[J]. 中华医院感染学杂志,2022(1):104-108. 安娜,段颜,杨鑫鑫,等. 宫颈上皮内瘤样病变患者阴道微环境平衡和HPV感染及危险因素[J]. 中华医院感染学杂志,2022(1):104-108.
15、 SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer Statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1):7-33. SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer Statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1):7-33.
16、 武丽, 黄千峰, 纪存委,等. 宫颈癌不同初筛方法检出率及随访质量评价[J]. 中国公共卫生, 2018, 10(34): 1380-1382. 武丽, 黄千峰, 纪存委,等. 宫颈癌不同初筛方法检出率及随访质量评价[J]. 中国公共卫生, 2018, 10(34): 1380-1382.
17、 李月菊. HPV联合TCT检测对宫颈病变诊断的预测价值[J]. 广州医药,2021, 52(3): 48-51. 李月菊. HPV联合TCT检测对宫颈病变诊断的预测价值[J]. 广州医药,2021, 52(3): 48-51.
18、 唐凤祝,简洁,梁开如,等. 21776例女性人乳头瘤病毒感染情况及亚型分布与宫颈细胞病变的相关性分析[J]. 中国计划生育和妇产科,2021, 13(5), 92-96. 唐凤祝,简洁,梁开如,等. 21776例女性人乳头瘤病毒感染情况及亚型分布与宫颈细胞病变的相关性分析[J]. 中国计划生育和妇产科,2021, 13(5), 92-96.
19、 BOSH F X, LORINCZ A, MUNOZ N, et al. The causal relation between human papillomavirus and cervical cancer [J]. J Clin Pathol, 2002, 55(4): 244-265. BOSH F X, LORINCZ A, MUNOZ N, et al. The causal relation between human papillomavirus and cervical cancer [J]. J Clin Pathol, 2002, 55(4): 244-265.
20、 SCHIFFMAN M, WENTZENSEN N, WACHOLDER S, et al. Human papilomavirus testing in the prevention of cervical cancer [J]. J Natl Cancer Inst, 2016, 103(19): 368-383. SCHIFFMAN M, WENTZENSEN N, WACHOLDER S, et al. Human papilomavirus testing in the prevention of cervical cancer [J]. J Natl Cancer Inst, 2016, 103(19): 368-383.
21、 中国抗癌协会妇科肿瘤专业委员会.子宫颈癌诊断与治疗指南 (2021年版)[J]. 中国癌症杂志 ,2021,31(6):474-489. 中国抗癌协会妇科肿瘤专业委员会.子宫颈癌诊断与治疗指南 (2021年版)[J]. 中国癌症杂志 ,2021,31(6):474-489.
22、 乔友林,李静.子宫颈癌筛查方法新进展[J]. 医学研究杂志,2009,38(11):3-4. 乔友林,李静.子宫颈癌筛查方法新进展[J]. 医学研究杂志,2009,38(11):3-4.
23、 郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志,2019,1(41):19-28. 郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志,2019,1(41):19-28.
1、黎思毅,胡汉斌,罗雪平,等.广州市花都区某医院妇科门诊HPV感染基因亚型情况分析[J].现代医院,2024,24(05):803-805+809. 黎思毅,胡汉斌,罗雪平,等.广州市花都区某医院妇科门诊HPV感染基因亚型情况分析[J].现代医院,2024,24(05):803-805+809.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录